Lavina Gharu, Rajesh Ringe, Jayanta Bhattacharya, Lavina Gharu, Rajesh Ringe, Jayanta Bhattacharya, Lavina Gharu, Rajesh Ringe, Jayanta Bhattacharya
Index: Virus Res. 158(1-2) , 216-24, (2011)
Full Text: HTML
Highlights ► Compared envelopes with expanded coreceptor tropism with those that are strictly CCR5 using for their capacity to utilize CD4 and CCR5. ► Low CD4 dependent envelopes infect primary cells better than those that required optimum CD4 for entry ► No association between low CD4 usage and sensitivity to TAK-779 ► Envelopes with low CD4 usage showed relative resistance to T-20 ► Data throw important insight in disease transmission in late stage in context of subtype C HIV-1 variants.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
TAK-779
CAS:229005-80-5 |
C33H39ClN2O2 |
|
Effects of a calcineurin inhibitor, FK506, and a CCR5/CXCR3 ...
2011-07-01 [Transpl. Immunol. 25(1) , 49-55, (2011)] |
|
Evolution of CCR5 antagonist resistance in an HIV-1 subtype ...
2010-12-01 [J. Acquir. Immune Defic. Syndr. 55(4) , 420-7, (2010)] |
|
Synthesis of [19, 35, 36-(13)C(3)]-labeled TAK779 as a molec...
2009-08-15 [Bioorg. Med. Chem. 17(16) , 5769-74, (2009)] |
|
HIV-1 clinical isolates resistant to CCR5 antagonists exhibi...
2012-01-01 [J. Virol. 86(2) , 1119-28, (2012)] |
|
C-C chemokine receptor type 5 (CCR5) utilization of transmit...
2010-12-01 [J. Gen. Virol. 91(Pt 12) , 2965-73, (2010)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
